Actively Recruiting
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
Led by Sohag University · Updated on 2025-05-01
100
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. assess the impact of albumin level on clinical course and outcomes of HE.
CONDITIONS
Official Title
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged over 18 years
- Confirmed chronic liver disease by imaging, liver function tests, and clinical history
- Diagnosed with hepatic encephalopathy based on clinical criteria
- Able to provide informed consent
You will not qualify if you...
- Patients under 18 years old
- Acute liver failure
- Chronic renal failure on dialysis
- Pregnant women
- Patients with active malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sohag university hospital
Sohag, Egypt
Actively Recruiting
Research Team
K
Kerelos L Sweha, Resident
CONTACT
H
Hamdy S Mohamed, Assist.prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here